Arcellx Inc (ACLX)
54.72
+1.47
(+2.76%)
USD |
NASDAQ |
Jul 03, 16:00
Arcellx EPS Diluted (Annual): -1.47 for Dec. 31, 2023
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -1.47 |
December 31, 2022 | -5.19 |
December 31, 2021 | -1.937 |
Date | Value |
---|---|
December 31, 2020 | -1.474 |
December 31, 2019 | -1.667 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
-5.19
Minimum
2022
-1.47
Maximum
2023
-2.348
Average
-1.667
Median
2019
EPS Diluted (Annual) Benchmarks
BridgeBio Pharma Inc | -3.95 |
Gilead Sciences Inc | 4.50 |
Agios Pharmaceuticals Inc | -6.33 |
Krystal Biotech Inc | 0.39 |
Arvinas Inc | -6.62 |